Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02959437
Title Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

colorectal cancer

Therapies

Azacitidine + Epacadostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.